A simple method for decellularizing a cell-derived matrix for bone cell cultivation and differentiation.


Journal

Journal of materials science. Materials in medicine
ISSN: 1573-4838
Titre abrégé: J Mater Sci Mater Med
Pays: United States
ID NLM: 9013087

Informations de publication

Date de publication:
15 Sep 2021
Historique:
received: 29 06 2021
accepted: 29 08 2021
entrez: 15 9 2021
pubmed: 16 9 2021
medline: 27 1 2022
Statut: epublish

Résumé

The extracellular matrix regulates cell survival, proliferation, and differentiation. In vitro two-dimensional cell experiments are typically performed on a plastic plate or a substrate of a single extracellular matrix constituent such as collagen or calcium phosphate. As these approaches do not include extracellular matrix proteins or growth factors, they fail to mimic a complex cell microenvironment. The cell-derived matrix is an alternative platform for better representing the in vivo microenvironment in vitro. Standard decellularization of a cell-derived matrix is achieved by combining chemical and physical methods. In this study, we compared the decellularization efficacy of several methods: ammonium hydroxide, sodium dodecyl sulfate (SDS), or Triton X-100 with cold or heat treatment on a matrix of Saos-2 cells. We found that the protocols containing SDS were cytotoxic during recellularization. Heat treatment at 47 °C was not cytotoxic, removed cellular constituents, inactivated alkaline phosphatase activity, and maintained the levels of calcium deposition. Subsequently, we investigated the differentiation efficiency of a direct bone coculture system in the established decellularized Saos-2 matrix, an inorganic matrix of calcium phosphate, and a plastic plate as a control. We found that the decellularized Saos-2 cell matrix obtained by heat treatment at 47 °C enhanced osteoclast differentiation and matrix mineralization better than the inorganic matrix and the control. This simple and low-cost method allows us to create a Saos-2 decellularized matrix that can be used as an in vivo-like support for the growth and differentiation of bone cells.

Identifiants

pubmed: 34524552
doi: 10.1007/s10856-021-06601-y
pii: 10.1007/s10856-021-06601-y
pmc: PMC8443471
doi:

Substances chimiques

Calcium Phosphates 0
Decellularized Extracellular Matrix 0
calcium phosphate 97Z1WI3NDX

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

124

Informations de copyright

© 2021. The Author(s).

Références

Bone. 1995 Apr;16(4):415-26
pubmed: 7605701
Biomaterials. 2009 Sep;30(26):4260-7
pubmed: 19481081
Int J Mol Sci. 2020 Jun 24;21(12):
pubmed: 32599901
Eur J Cancer. 1995;31A(3):375-80
pubmed: 7540403
Biomaterials. 2005 May;26(15):2575-84
pubmed: 15585260
J Biomed Mater Res. 2001;58(5):570-92
pubmed: 11505433
J Mol Med (Berl). 2012 Nov;90(11):1257-66
pubmed: 22926010
J Cell Physiol. 2011 Dec;226(12):3413-21
pubmed: 21344395
Biomaterials. 2011 Apr;32(12):3233-43
pubmed: 21296410
J Cell Mol Med. 2008 Aug;12(4):1347-59
pubmed: 18318690
Acta Orthop. 2007 Apr;78(2):221-5
pubmed: 17464610
Arch Toxicol. 2018 Apr;92(4):1525-1538
pubmed: 29264620
Biomaterials. 2007 Mar;28(7):1393-403
pubmed: 17166582
J Biomed Mater Res B Appl Biomater. 2014 Jul;102(5):903-12
pubmed: 24259122
Bioengineering (Basel). 2020 Jun 05;7(2):
pubmed: 32517006
Arch Toxicol. 2017 Mar;91(3):1353-1366
pubmed: 27394662
Int J Biochem Cell Biol. 2015 Aug;65:20-31
pubmed: 25997875
Bone. 2019 Mar;120:411-422
pubmed: 30529011
Proc Natl Acad Sci U S A. 2014 Dec 9;111(49):17426-31
pubmed: 25422415
J Am Soc Nephrol. 2018 May;29(5):1557-1565
pubmed: 29555831
Bioeng Transl Med. 2018 Oct 26;4(1):83-95
pubmed: 30680321
Mater Sci Eng C Mater Biol Appl. 2018 Apr 1;85:191-202
pubmed: 29407148
Cells. 2019 May 11;8(5):
pubmed: 31083501
Int J Mol Sci. 2020 Dec 23;22(1):
pubmed: 33374546
World J Stem Cells. 2020 Aug 26;12(8):841-856
pubmed: 32952862
Science. 2009 Nov 27;326(5957):1216-9
pubmed: 19965464
Int J Oral Maxillofac Surg. 2013 Jan;42(1):140-6
pubmed: 22571861
Curr Pharm Des. 2009;15(12):1334-48
pubmed: 19355972
J Cell Sci. 2010 Dec 15;123(Pt 24):4195-200
pubmed: 21123617
Endocr Rev. 1993 Aug;14(4):424-42
pubmed: 8223340
Cytotechnology. 2008 Feb;56(2):71-9
pubmed: 19002844
Glycoconj J. 2009 Feb;26(2):219-27
pubmed: 18763033
J Cell Biochem. 2010 Apr 1;109(5):1025-32
pubmed: 20108253
Eur Cell Mater. 2017 Jan 18;33:28-42
pubmed: 28098926
Colloids Surf B Biointerfaces. 2015 Feb 1;126:381-6
pubmed: 25516267
PLoS One. 2010 Sep 27;5(9):e13039
pubmed: 20885963
J Mater Chem B. 2017 Jun 21;5(23):4322-4331
pubmed: 32263962
Oxid Med Cell Longev. 2018 Nov 6;2018:3172480
pubmed: 30533170
J Thorac Cardiovasc Surg. 2004 Feb;127(2):399-405
pubmed: 14762347
Cytotherapy. 2011 Jul;13(6):661-74
pubmed: 21250865
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:627-638
pubmed: 28576031

Auteurs

Weidong Weng (W)

Department of Trauma and Reconstructive Surgery, BG Trauma Center Tübingen, Siegfried Weller Institute for Trauma Research, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.

Filippo Zanetti (F)

PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

David Bovard (D)

PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Bianca Braun (B)

Department of Trauma and Reconstructive Surgery, BG Trauma Center Tübingen, Siegfried Weller Institute for Trauma Research, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.

Sabrina Ehnert (S)

Department of Trauma and Reconstructive Surgery, BG Trauma Center Tübingen, Siegfried Weller Institute for Trauma Research, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.

Tatiana Uynuk-Ool (T)

Department of Trauma and Reconstructive Surgery, BG Trauma Center Tübingen, Siegfried Weller Institute for Trauma Research, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.

Tina Histing (T)

Department of Trauma and Reconstructive Surgery, BG Trauma Center Tübingen, Siegfried Weller Institute for Trauma Research, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.

Julia Hoeng (J)

PMI R&D, Philip Morris Products S.A., Quai Jeanrenaud 5, CH-2000, Neuchâtel, Switzerland.

Andreas K Nussler (AK)

Department of Trauma and Reconstructive Surgery, BG Trauma Center Tübingen, Siegfried Weller Institute for Trauma Research, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.

Romina H Aspera-Werz (RH)

Department of Trauma and Reconstructive Surgery, BG Trauma Center Tübingen, Siegfried Weller Institute for Trauma Research, Eberhard Karls University Tübingen, 72076, Tübingen, Germany. rominaaspera@hotmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH